{"gene":"PRKCA","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2004,"finding":"PKCα directly phosphorylates protein phosphatase inhibitor-1 (I-1), thereby altering the activity of protein phosphatase-1 (PP-1), which in turn affects dephosphorylation of the SERCA-2 inhibitory protein phospholamban (PLB), modulating sarcoplasmic reticulum Ca2+ loading and the Ca2+ transient in cardiac myocytes. Loss of Prkca in mice produces hypercontractile hearts; overexpression produces hypocontractile hearts.","method":"Prkca knockout mice, cardiac-specific transgenic overexpression, adenoviral dominant-negative/wild-type gene transfer into cardiomyocytes, biochemical phosphorylation assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vivo genetic models (KO and transgenic), adenoviral rescue, direct biochemical substrate identification, replicated across several cardiac disease models","pmids":["14966518"],"is_preprint":false},{"year":2009,"finding":"PKCα is required for dense-granule biogenesis and secretion in platelets; Prkca−/− mice show attenuated thrombus formation in vivo and defective platelet aggregation in vitro that can be rescued by exogenous ADP, placing PKCα upstream of dense-granule secretion and thrombus formation.","method":"Prkca knockout mice, in vivo thrombosis model, in vitro platelet aggregation and secretion assays, ADP rescue experiment","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple orthogonal functional assays (in vivo thrombosis, in vitro aggregation, granule secretion) and mechanistic rescue","pmids":["19147982"],"is_preprint":false},{"year":2003,"finding":"PKCα acts upstream of PKCθ to activate the IKK complex and NF-κB–dependent transcription following TCR/CD28 co-stimulation. An early phase (1–5 min) of IKK activation is PKCα-dependent and requires Ca2+-binding residues D246/D248 for membrane recruitment; a later phase (5–25 min) is PKCθ-dependent. Catalytically active PKCαA25E drives NF-κB transcription, and this is abrogated by kinase-inactive PKCθ.","method":"Genetic analysis (dominant-negative/constitutively active constructs), pharmacological inhibition, RNA interference, kinetic IKK activation assays in T lymphocytes","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis established by multiple complementary approaches (RNAi, pharmacological inhibition, mutagenesis of Ca2+-binding residues, kinetic analysis)","pmids":["12972622"],"is_preprint":false},{"year":2007,"finding":"Light exposure in the SCN evokes a transient interaction between PRKCA and PERIOD 2 (PER2) protein that affects PER2 stability and nucleocytoplasmic distribution; Prkca-deficient mice show impaired light-mediated circadian clock resetting, identifying PKCα as a component of a posttranslational photic input pathway.","method":"Prkca knockout mice, behavioral circadian assays, co-immunoprecipitation of PRKCA–PER2 interaction in SCN, subcellular fractionation of PER2","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO phenotype combined with direct protein interaction and localization data in relevant tissue","pmids":["17553429"],"is_preprint":false},{"year":2011,"finding":"Calpain-mediated proteolytic processing of PKCα in ischemic myocardium releases a constitutively active free catalytic fragment (PKCα-CT) that localizes to nuclei, directly promotes HDAC5 nucleo-cytoplasmic shuttling independently of PKD, and induces MEF2-dependent pathological cardiac gene expression.","method":"Expression of PKCα-CT in cardiomyocytes, nuclear fractionation, HDAC5 localization assays, comparison with phorbol ester-activated full-length PKCα requiring PKD","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic distinction from full-length PKCα established with subcellular localization and gene expression readouts in a single lab","pmids":["21642422"],"is_preprint":false},{"year":2012,"finding":"PKCα directly binds and phosphorylates G3BP2 via its regulatory domain interacting with the C-terminal RNA-binding domain of G3BP2; both proteins co-localize in stress granules (but not P-bodies) upon stress, and PKCα knockdown suppresses heat-shock-induced stress granule assembly and eIF2α phosphorylation.","method":"Co-immunoprecipitation, RNase-resistance assay, in vitro kinase assay with recombinant proteins, siRNA knockdown, live-cell imaging of stress granule formation","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro phosphorylation with recombinant proteins, domain-mapping, functional KD phenotype in single lab with multiple orthogonal methods","pmids":["22536444"],"is_preprint":false},{"year":2012,"finding":"Annexin A6 (AnxA6) acts as a scaffold that recruits PKCα to the plasma membrane, facilitating PKCα-mediated phosphorylation of EGFR at T654, inhibiting EGFR tyrosine phosphorylation and downstream activation. AnxA6 N-terminal mutant unable to recruit PKCα to the membrane fails to increase T654-EGFR phosphorylation; the T654A EGFR mutant is not inhibited by AnxA6 overexpression.","method":"Ectopic AnxA6 expression, PKCα siRNA knockdown, AnxA6(1-175) cytosolic mutant and plasma-membrane-anchored AnxA6, T654A EGFR mutant, Co-IP of AnxA6–EGFR–PKCα complex","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple gain/loss-of-function constructs, domain mutants, substrate phospho-site mutant, and complex Co-IP in a single rigorous study","pmids":["22797061"],"is_preprint":false},{"year":2013,"finding":"PKCα physically interacts and functionally cooperates with TGFβRI to promote robust SMAD2/3 activation, selectively upregulating IL-17A (but not IL-17F) in Th17 cells. Prkca−/− cells show defective SMAD-dependent IL-2 suppression and decreased STAT3 DNA binding at the Il17a promoter, and are resistant to Th17-cell-dependent EAE.","method":"Prkca knockout mice, Co-IP of PKCα–TGFβRI interaction, SMAD2/3 phosphorylation assays, STAT3 ChIP, in vivo EAE model","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO, direct interaction by Co-IP, multiple downstream signaling readouts, in vivo disease model","pmids":["23290522"],"is_preprint":false},{"year":2015,"finding":"PKCα interacts with TRM61, the catalytic subunit of the TRM6/61 tRNA methyltransferase complex. Elevated TRM6/61 increases translation of tumorigenic mRNAs via tRNAiMet stabilization, and PKCα overexpression in TRM6/61-overexpressing cells decreases tRNAiMet expression and tumorigenic colony/sphere formation, indicating PKCα controls TRM6/61 activity to prevent translational deregulation.","method":"Co-immunoprecipitation of PKCα–TRM61, tRNAiMet expression assays, colony and sphere formation assays with PKCα overexpression vs. TRM6/61 overexpression","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and functional rescue in a single lab; mechanistic link to translational control supported by multiple assays","pmids":["26234676"],"is_preprint":false},{"year":2008,"finding":"PKCα knockdown in endothelial cells increases VEGFR2 tyrosine phosphorylation, protein and mRNA expression, and enhances VEGF-stimulated Akt/eNOS phosphorylation, demonstrating that PKCα negatively regulates VEGFR2 expression and VEGF signaling (opposite to PKCε which positively regulates VEGFR2).","method":"siRNA knockdown of PKCα (and PKCε/δ for comparison), VEGFR2 phosphorylation and expression assays, Akt/eNOS phosphorylation, DNA synthesis assay","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-selective siRNA with multiple downstream readouts in a single lab","pmids":["18323518"],"is_preprint":false},{"year":2002,"finding":"Mechanical stimulation of human articular chondrocytes induces rapid β1 integrin–dependent translocation of PKCα to the cell membrane and increased association of the scaffolding protein RACK1 with both PKCα and β1 integrin, placing RACK1 as a mechanotransduction intermediary for PKCα membrane recruitment.","method":"Mechanical stimulation of chondrocytes, anti-integrin antibody blocking, subcellular fractionation, Co-IP of RACK1–PKCα–β1 integrin","journal":"Osteoarthritis and cartilage","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with integrin-blocking functional link, single lab","pmids":["12435334"],"is_preprint":false},{"year":2016,"finding":"K5/K14 keratins sequester PKCα in the cytoplasm, whereas wound-healing keratins K6/K17 enable PKCα translocation to the plasma membrane, promoting PKCα-mediated desmosome disassembly. Gain- and loss-of-function of K5 modulates desmosome stability via PKCα.","method":"Stable re-expression of keratin isotypes in keratin-null keratinocytes, live-cell imaging of PKCα localization, desmosome stability/adhesion assays, PKCα gain/loss-of-function","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — controlled genetic system with multiple functional assays, single lab","pmids":["26763440"],"is_preprint":false},{"year":2020,"finding":"Elevated cytosolic Ca2+ activates PKCα, which phosphorylates the Golgi stacking protein GRASP55, causing Golgi fragmentation. PKCα activation by PMA or histamine also modulates Golgi structure in the same manner; this pathway operates independently of ER stress.","method":"Thapsigargin/PMA/histamine treatment of HeLa cells, PKCα activity inhibition, GRASP55 phosphorylation assays, Golgi morphology imaging","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct substrate phosphorylation (GRASP55) with pharmacological PKCα inhibition and multiple activating stimuli, single lab","pmids":["32179476"],"is_preprint":false},{"year":2004,"finding":"PKCα overexpression in undifferentiated mouse keratinocytes induces differentiation markers (loricrin, filaggrin, K1, K10) and ERK1/2 phosphorylation without affecting p38 or JNK; dominant-negative PKCα blocks Ca2+-mediated differentiation markers; MEK inhibition blocks PKCα-mediated differentiation, placing PKCα→ERK1/2 as the specific pathway for PKCα-driven keratinocyte differentiation.","method":"Adenoviral overexpression and dominant-negative PKCα in keratinocytes, differentiation marker assays, MEK/p38/JNK inhibitors, ERK1/2 dominant-negative constructs","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain/loss-of-function with isoform-specific dominants and pathway inhibitors in a single lab","pmids":["15365248"],"is_preprint":false},{"year":2015,"finding":"PKCα regulates TMEM16A-mediated Cl− secretion in biliary epithelial cells: extracellular ATP induces PKCα translocation from cytosol to plasma membrane; intracellular dialysis with recombinant PKCα activates Cl− currents indistinguishable from TMEM16A; these currents are absent after TMEM16A siRNA, demonstrating direct functional coupling of PKCα to TMEM16A.","method":"Whole-cell patch-clamp, intracellular dialysis with recombinant PKCα, PKCα siRNA, TMEM16A siRNA, subcellular fractionation","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with recombinant protein (intracellular dialysis) combined with siRNA knockdown and electrophysiology in single lab","pmids":["26542395"],"is_preprint":false},{"year":2022,"finding":"PKCα directly phosphorylates ZFP64 at S226, leading to its nuclear translocation and transcriptional activation of CSF1, which transforms macrophages toward M2 polarization to drive immune evasion and anti-PD1 resistance in hepatocellular carcinoma.","method":"Mass spectrometry, phospho-site mutagenesis, nuclear translocation assays, chromatin immunoprecipitation, in vitro co-culture, orthotopic HCC xenograft model","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct phosphorylation site identified by MS, validated by mutagenesis, ChIP, and in vivo model in a single comprehensive study","pmids":["35219791"],"is_preprint":false},{"year":2016,"finding":"PKCα phosphorylates CK1δ at C-terminal residues S328, T329, and S370 in vitro; mutation of these sites dramatically alters CK1δ kinetic parameters; pharmacological PKCα inhibition in cells reduces CK1δ activity, demonstrating that PKCα is a regulator of CK1δ kinase activity.","method":"In vitro kinase assay (PKCα phosphorylating CK1δ), site-directed mutagenesis of CK1δ phospho-sites, Go-6983 PKCα inhibitor in cell culture, kinetic analysis","journal":"Amino acids","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and cellular validation, single lab","pmids":["26803658"],"is_preprint":false},{"year":2018,"finding":"PKCα interacts with ULK1 through the ULK1 serine/threonine-rich (S/T) domain; phospho-PKCα phosphorylates ULK1 at Ser317/555/777 and Raptor, promoting mitophagy and replacing AMPK-dependent mitophagy during PEDF-induced cardioprotection in OGD cardiomyocytes. A ULK1 deletion mutant lacking the S/T domain fails to mediate PEDF-induced mitophagy.","method":"Co-IP of PKCα–ULK1 interaction, deletion mutagenesis of ULK1, phosphorylation assays, mitophagy markers, OGD cardiomyocyte model","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction by Co-IP with domain mapping and phospho-site identification, single lab","pmids":["30230261"],"is_preprint":false},{"year":2016,"finding":"PKCα phosphorylates filamin C (FLNc) at distinct serine residues in its hinge 2 region, preventing calpain 1 cleavage at an adjacent tyrosine. FRAP analysis shows this phosphorylation modulates FLNc dynamics at Z-discs in contracting skeletal myotubes.","method":"Quantitative phosphoproteomics of Z-disc in electrically stimulated myotubes, in vitro PKCα phosphorylation assay, FRAP, FLNc cleavage assays","journal":"Molecular & cellular proteomics : MCP","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay, FRAP functional validation, and phosphoproteomics in a single rigorous study","pmids":["28028127"],"is_preprint":false},{"year":2020,"finding":"PKCα positively regulates Rac1 activation during single-spine structural plasticity in dendritic spines; removal of PKCα expression attenuates Rac1 (but not Ras or Cdc42) activation. Disruption of a PDZ binding domain within PKCα impairs Rac1 activation and structural spine remodeling, positioning PKCα upstream of Rac1 in actin-dependent synaptic plasticity.","method":"PKCα knockdown/knockout in postsynaptic spines, FRET-based biosensors for Rac1/Cdc42/Ras activity during single-spine structural plasticity, PDZ domain mutant of PKCα","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific KO with live biosensor imaging and domain-mutant, single lab","pmids":["32019972"],"is_preprint":false},{"year":2011,"finding":"Pharmacological inhibition of PKCα/β with ruboxistaurin in a pig model of myocardial infarction-induced heart failure improves contractility, ejection fraction, and cardiac output, extending the mouse/rat cardiac contractility findings to a large-animal model.","method":"Left anterior descending artery occlusion in pigs, ruboxistaurin oral administration, echocardiographic measurements over 3 months","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition in large-animal model, single lab, extends earlier mechanistic findings","pmids":["21998327"],"is_preprint":false},{"year":2018,"finding":"The recurrent PRKCA D463H kinase-domain mutation found in all chordoid gliomas is a gain-of-function mutation; expression of mutant PRKCA in immortalized astrocytes increases phospho-ERK and anchorage-independent growth that is blocked by MEK inhibition, implicating the MAPK pathway downstream of mutant PKCα.","method":"Genomic sequencing of 13 chordoid gliomas, expression of PRKCA D463H in immortalized astrocytes, phospho-ERK assays, MEK inhibitor treatment, soft-agar colony formation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — recurrent mutation identified by sequencing, functional gain-of-function validated in cell model with signaling and MEK inhibitor rescue, replicated in two independent studies (PMIDs 29476136 and 29915258)","pmids":["29476136","29915258"],"is_preprint":false},{"year":2018,"finding":"The PKCα D463H mutant protein is depleted from the cell membrane compared to wild-type PKCα, is less stable, and its mRNA is more abundant than wild-type, with enriched activation of the EIF2 translation-initiation pathway. The mutant enhances proliferation of astrocytes and tanycytes.","method":"Whole-exome and RNA-sequencing of ChG, subcellular fractionation of PKCαD463H vs WT, protein stability assays, pathway activation analysis, proliferation assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization/stability comparisons of mutant vs WT protein in single study","pmids":["29915258"],"is_preprint":false},{"year":2015,"finding":"PKCα promotes ROS production in hepatocellular carcinoma cells by upregulating DUOX2 at the post-transcriptional level; depletion of DUOX2 abrogates PKCα-induced AKT/MAPK pathway activation and cell proliferation, migration, and invasion.","method":"PKCα overexpression/knockdown in HCC cells, DUOX2 knockdown, ROS measurement, AKT/MAPK phosphorylation assays, proliferation/migration/invasion assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistatic ordering of PKCα→DUOX2→AKT/MAPK with KO/KD functional readouts, single lab","pmids":["26056003"],"is_preprint":false},{"year":2021,"finding":"ECM stiffness activates PKCα which promotes nuclear transport of DNMT3L; stiff ECM leads to global hypermethylation (particularly at pluripotent gene promoters) in a PKCα-dependent manner. DNMT3L binds the Nanog promoter during cell–ECM interactions.","method":"Polyacrylamide gel substrates of varying stiffness, PKCα inhibition/knockdown, DNMT3L nuclear fractionation, methylation assays, ChIP of DNMT3L at Nanog promoter","journal":"Advanced healthcare materials","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — PKCα-dependent nuclear transport with functional epigenetic readout, single lab","pmids":["34174172"],"is_preprint":false},{"year":2014,"finding":"PKCα and PKCδ phosphorylate the progesterone receptor (PR) at Ser400 within minutes of PKC activation, inducing PR transcriptional activity and subsequent proteasomal degradation. PR directly associates with PKCα (maximally at 5 min post-TPA), and PR Ser400Ala mutant blocks PKC-mediated PR phosphorylation and degradation.","method":"TPA treatment, siRNA silencing and pharmacological inhibition of PKCα/PKCδ, Co-IP of PR–PKCα, immunofluorescence nuclear colocalization, PR S400A mutant, luciferase reporter, proteasome inhibitor","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction by Co-IP, phospho-site mutant validation, multiple functional readouts, single lab","pmids":["25514083"],"is_preprint":false},{"year":2016,"finding":"H2O2-induced poly-ADP-ribose (PAR) formation is mediated by the PLC/IP3R/Ca2+/PKCα signaling axis; PKCα knockdown completely abolishes PAR formation despite persistent DNA damage. Co-depletion of HMGB1 with PKCα restores PAR formation, indicating PKCα activation releases HMGB1-mediated inhibition of PAR synthesis.","method":"RPPA signaling analysis, PKCα siRNA, HMGB1 siRNA, Ca2+ chelation, PAR quantification, DNA damage markers","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistatic ordering with two co-depletion experiments and pathway pharmacology, single lab","pmids":["27198223"],"is_preprint":false},{"year":2017,"finding":"PKCα-mediated phosphorylation of T. gondii GRA7 at Ser52 regulates interaction of GRA7 with the PYD domain of ASC to promote inflammasome activation; PKCα-mediated phosphorylation of GRA7 at Ser135 facilitates interaction with the PX domain of PLD1, enhancing its enzyme activity and phago-lysosomal maturation for antimycobacterial defense.","method":"Phospho-site mutagenesis of GRA7 Ser52/Ser135, Co-IP of GRA7–ASC and GRA7–PLD1, PLD1 enzyme activity assay, phagolysosomal fusion assays, mycobacterial killing assays","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-site mutagenesis combined with functional interaction and enzyme activity assays, single lab","pmids":["28125719"],"is_preprint":false},{"year":2019,"finding":"PKCα promotes insulin secretion in INS-1E cells by phosphorylating TRPC1; inhibition of PKCα reduces TRPC1 phosphorylation and intracellular Ca2+ levels, reducing insulin secretion; TRPC1 overexpression reverses the decrease in Ca2+ and insulin secretion caused by PKCα inhibition.","method":"PKCα activation/inhibition in INS-1E cells, TRPC1 phosphorylation assays, intracellular Ca2+ measurement, insulin secretion assay, TRPC1 overexpression rescue","journal":"Bioscience, biotechnology, and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct substrate phosphorylation and functional rescue, single lab","pmids":["31094294"],"is_preprint":false},{"year":2014,"finding":"PKCα contributes to high NaCl-induced NFAT5 activation through ERK1/2 but not through SHP-1-S591 phosphorylation; Prkca knockout reduces ERK1/2 phosphorylation and NFAT5 target gene expression in the renal inner medulla; combined knockdown of PKCα and ERK2 has no greater effect than either alone, placing them in the same pathway.","method":"Prkca knockout mice (renal medulla analysis), siRNA knockdown in HEK293 cells, NFAT5 transcriptional activity assay, ERK1/2 phosphorylation, SHP-1 phosphorylation assays","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO and siRNA epistasis with multiple signaling readouts, single lab","pmids":["25391900"],"is_preprint":false},{"year":2006,"finding":"Polycystin-1 (PC1) cytoplasmic tail upregulates NF-κB nuclear levels and transcriptional activity in kidney cells through a PKCα-mediated mechanism; this anti-apoptotic pathway is blocked by the PKCα-specific inhibitor Ro-320432, and PC1-dependent antiapoptotic effects are reduced by PKC and NF-κB inhibitors.","method":"Stable expression of PC1 CTT in HEK293 cells, PKCα inhibitor Ro-320432, NF-κB luciferase reporter, apoptosis assays, RNA interference of endogenous PC1","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pharmacological inhibition with multiple functional readouts; PKCα specificity rests on a single inhibitor without direct PKCα activity measurement","pmids":["17007817"],"is_preprint":false},{"year":2023,"finding":"Gi/o GPCR activation drives tunneling nanotube (TNT) formation through a Gβγ→PLCβ3→PKCα signaling axis; PKCα-dependent phosphorylation of cofilin stabilizes actin in TNT structures. PKCα inhibition blocks TNT formation downstream of OXER1 and LPA receptors.","method":"Pertussis toxin treatment, PLCβ3 siRNA, PKCα inhibition/siRNA, cofilin phosphorylation assays, TNT quantification by microscopy","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway epistasis established by siRNA and pharmacological inhibition with structural and biochemical readouts, single lab","pmids":["37390986"],"is_preprint":false},{"year":2021,"finding":"LDB3 mutation (Ala165Val) impairs PKCα signaling at the Z-disc in skeletal muscle by disrupting LDB3 interactions with filamin C, HSPA8, and PKCα, leading to protein aggregation and Z-disc disruption; this is linked to TSC2-mTOR downregulation as a parallel pathway.","method":"Ldb3Ala165Val/+ knock-in mice, Co-IP of LDB3–filamin C–HSPA8–PKCα complex, PKCα activity assays, mTOR pathway analysis, histology of Z-disc","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction data and knock-in model with functional readouts, single lab","pmids":["33742095"],"is_preprint":false},{"year":2016,"finding":"PHF8 histone demethylase regulates PRKCA transcription by interacting with c-Jun on the PRKCA promoter; PKCα in turn activates Src, which destabilizes PTEN via the PKCα-Src axis in gastric cancer cells.","method":"ChIP of PHF8/c-Jun at PRKCA promoter, PHF8/PKCα knockdown and ectopic expression, Src activity and PTEN expression assays, zebrafish migration model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP at PRKCA promoter and epistatic rescue experiments, single lab","pmids":["32958674"],"is_preprint":false},{"year":2014,"finding":"In female Prkca−/− mice, PKCα normally suppresses endosteal bone formation by inhibiting osteoblast differentiation and Wnt target gene expression; within osteoblastic cells PKCα enhances proliferation and suppresses differentiation via the Wnt pathway. Estradiol and mechanical strain stimulate WT but not Prkca−/− osteoblastic cell proliferation.","method":"Prkca knockout mice (bone phenotype), osteoblast differentiation markers, Wnt target gene expression, estradiol/mechanical strain stimulation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple cellular and molecular readouts in bone, single lab","pmids":["25070889"],"is_preprint":false},{"year":2022,"finding":"TRPM7 channel activity elevates intracellular Ca2+ and drives chondrocyte ferroptosis via the PKCα–NOX4 axis; PKCα was shown to directly bind NOX4, and TRPM7 inhibition reduces this interaction. AAV9-mediated TRPM7 silencing and pharmacological TRPM7 blockade attenuate cartilage destruction in adjuvant arthritis rats.","method":"TRPM7 knockdown/pharmacological inhibition, Co-IP of PKCα–NOX4, intracellular Ca2+ measurement, ferroptosis markers, in vivo AA rat model with AAV9","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct PKCα–NOX4 interaction by Co-IP, in vivo genetic and pharmacological models, single lab","pmids":["35917680"],"is_preprint":false},{"year":2014,"finding":"Absence of PKCα (Prkca KO) prevents lithium-induced downregulation of aquaporin-2 (AQP2) and urea transporter UT-A1 in renal inner medullary collecting duct cells, and attenuates lithium-induced nephrogenic diabetes insipidus (polyuria), indicating PKCα mediates lithium-induced dysregulation of these water/urea channels.","method":"Prkca knockout mice, lithium treatment (acute and chronic), Western blot for AQP2/UT-A1 in medullary tissue, urine output and osmolality measurements","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with direct protein expression and physiological readouts, single lab","pmids":["25006961"],"is_preprint":false},{"year":2019,"finding":"Inhibition of ezrin disrupts the HER2–PMCA2–NHERF1–HSP90 membrane complex and causes PKCα-mediated internalization and degradation of HER2; inhibition of ezrin synergizes with lapatinib in a PKCα-dependent fashion to reduce proliferation and promote apoptosis in HER2-positive breast cancer cells.","method":"Ezrin knockdown/pharmacological inhibition, Co-IP of HER2–PMCA2–NHERF1–HSP90–ezrin complex, HER2 membrane retention assays, PKCα inhibition rescue, proliferation/apoptosis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP complex disruption with PKCα-dependent functional rescue, single lab","pmids":["30463939"],"is_preprint":false},{"year":2010,"finding":"PKCα suppresses osteoblastic differentiation (ALP activity, ALP/osteocalcin gene expression) but promotes osteoblastic cell proliferation; siRNA knockdown of PKCα increases differentiation markers, while wild-type PKCα overexpression decreases them in MC3T3-E1 cells.","method":"Gö6976 inhibitor, PKCα siRNA knockdown, wild-type PKCα overexpression, ALP activity assay, gene expression analysis","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition, siRNA KD, and overexpression with multiple differentiation readouts, single lab","pmids":["20951242"],"is_preprint":false},{"year":2012,"finding":"Integrin αv upregulates PKCα expression in a 3D collagen microenvironment; PKCα promotes cytoplasmic relocalization of p53 from the nucleus, suppressing p53 activity and promoting melanoma cell survival; stable knockdown of PKCα inhibits integrin αv-mediated p53 relocalization and promotes apoptosis in 3D collagen and in vivo.","method":"Microarray (integrin αv KD), stable PKCα knockdown, p53 subcellular fractionation in 3D collagen and in vivo, apoptosis assays, tumor xenograft","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — stable KD with in vivo validation and direct localization readout, single lab","pmids":["22773839"],"is_preprint":false}],"current_model":"PKCα (PRKCA) is a Ca2+- and diacylglycerol-activated serine/threonine kinase that operates as a nodal signaling integrator: it phosphorylates diverse substrates including inhibitor-1 (I-1, regulating PP-1/phospholamban/cardiac contractility), EGFR-T654 (via AnxA6 scaffolding to inactivate EGFR), ZFP64-S226 (driving CSF1 transcription and immune evasion), GRASP55 (modulating Golgi structure in response to Ca2+), filamin C hinge-2 serines (preventing calpain cleavage at Z-discs), CK1δ C-terminal serines (altering CK1δ activity), TRPC1 (promoting insulin secretion), and GRA7 (regulating inflammasome and phagolysosomal defense); it also acts as an upstream activator of IKK/NF-κB (via PKCθ in T cells), ERK1/2, Rac1 (in synaptic structural plasticity), and DUOX2-dependent ROS production, while its subcellular membrane recruitment is controlled by scaffolds RACK1, AnxA6, and keratin isotypes; gain-of-function kinase-domain mutation D463H (found in all chordoid gliomas) constitutively activates MAPK/ERK and displaces PKCα from the membrane, and calpain-generated catalytic fragments constitutively drive nuclear HDAC5 export and pathological gene expression in the heart."},"narrative":{"mechanistic_narrative":"PKCα (PRKCA) is a Ca2+- and lipid-responsive serine/threonine kinase that functions as a membrane-recruited signaling integrator, converting Ca2+ and diacylglycerol cues into phosphorylation of structural, transcriptional, and channel substrates across many tissues [PMID:14966518, PMID:32179476]. Its activity is gated by membrane recruitment, which is directed by dedicated scaffolds and cytoskeletal partners: AnxA6 brings PKCα to the plasma membrane to phosphorylate EGFR-T654 and dampen EGFR signaling [PMID:22797061], RACK1 couples β1-integrin mechanotransduction to PKCα translocation [PMID:12435334], and keratin isotypes either sequester PKCα (K5/K14) or license its translocation to drive desmosome disassembly (K6/K17) [PMID:26763440]. Once active, PKCα phosphorylates a broad substrate set with tissue-specific consequences: inhibitor-1 to control PP-1/phospholamban and cardiac contractility [PMID:14966518], the Golgi stacking protein GRASP55 to fragment the Golgi upon Ca2+ rise [PMID:32179476], filamin C hinge-2 serines to block calpain cleavage at Z-discs [PMID:28028127], CK1δ C-terminal residues to tune its kinase activity [PMID:26803658], TRPC1 to promote insulin secretion [PMID:31094294], and the transcription factor ZFP64-S226 to activate CSF1 and macrophage-driven immune evasion [PMID:35219791]. PKCα also operates as an upstream pathway activator—initiating an early Ca2+-dependent phase of IKK/NF-κB activation in T cells [PMID:12972622], driving ERK1/2-dependent keratinocyte differentiation and NFAT5 activation [PMID:15365248, PMID:25391900], and promoting Rac1 activation in dendritic-spine structural plasticity [PMID:32019972]. A recurrent gain-of-function kinase-domain mutation, D463H, found in chordoid gliomas, constitutively activates MAPK/ERK signaling while displacing the mutant protein from the membrane [PMID:29476136, PMID:29915258]. In ischemic myocardium, calpain-generated catalytic fragments of PKCα act constitutively in the nucleus to drive HDAC5 export and pathological gene expression [PMID:21642422], and pharmacological PKCα/β inhibition improves contractility in a large-animal heart-failure model [PMID:21998327].","teleology":[{"year":2003,"claim":"Established that PKCα acts as the Ca2+-dependent initiator of NF-κB signaling upstream of PKCθ, resolving how early TCR/CD28 signals reach IKK.","evidence":"Constitutively active/dominant-negative constructs, RNAi, pharmacology, and Ca2+-binding-residue mutagenesis in T lymphocytes with kinetic IKK assays","pmids":["12972622"],"confidence":"High","gaps":["Direct IKK substrate of PKCα not defined","Physical PKCα–PKCθ ordering inferred from kinetics, not co-complex"]},{"year":2004,"claim":"Defined PKCα as a direct regulator of cardiac contractility via I-1/PP-1/phospholamban, establishing a substrate-level mechanism with whole-organ consequences.","evidence":"Prkca KO and cardiac transgenic mice, adenoviral gene transfer in cardiomyocytes, biochemical phosphorylation assays","pmids":["14966518"],"confidence":"High","gaps":["Upstream activator of cardiac PKCα in vivo not isolated","Relative contribution of other PKCα cardiac substrates unaddressed"]},{"year":2007,"claim":"Placed PKCα in a posttranslational photic input pathway by linking it to PER2 stability and circadian resetting.","evidence":"Prkca KO mice, behavioral circadian assays, PRKCA–PER2 Co-IP and PER2 fractionation in SCN","pmids":["17553429"],"confidence":"High","gaps":["Whether PER2 is a direct PKCα phospho-substrate not shown","Phospho-site on PER2 unmapped"]},{"year":2009,"claim":"Showed PKCα is required for platelet dense-granule secretion and thrombus formation, with ADP rescue ordering it upstream of granule release.","evidence":"Prkca KO mice, in vivo thrombosis and in vitro aggregation/secretion assays with ADP rescue","pmids":["19147982"],"confidence":"High","gaps":["Granule-secretion substrate of PKCα not identified"]},{"year":2012,"claim":"Identified scaffold-directed membrane recruitment as the control point for PKCα substrate selection, exemplified by AnxA6-mediated EGFR-T654 phosphorylation and EGFR inactivation.","evidence":"AnxA6 gain/loss constructs, cytosolic and membrane-anchored AnxA6 mutants, T654A EGFR mutant, PKCα siRNA, ternary Co-IP","pmids":["22797061"],"confidence":"High","gaps":["Generality of AnxA6 scaffolding to other PKCα substrates untested"]},{"year":2016,"claim":"Expanded the PKCα substrate map to structural and regulatory targets—filamin C, CK1δ—demonstrating direct phosphorylation events with defined functional consequences.","evidence":"In vitro kinase assays, phosphoproteomics, site-directed mutagenesis, FRAP, kinetic analysis, cellular PKCα inhibition","pmids":["28028127","26803658"],"confidence":"High","gaps":["In vivo relevance of CK1δ phosphorylation by PKCα not established","Trigger for PKCα activation at the Z-disc not defined"]},{"year":2018,"claim":"Identified the recurrent D463H kinase-domain mutation as a gain-of-function oncogenic driver acting through MAPK/ERK in chordoid glioma.","evidence":"Genomic sequencing of chordoid gliomas, expression of D463H in astrocytes, phospho-ERK and soft-agar assays with MEK inhibition, replicated in two studies","pmids":["29476136","29915258"],"confidence":"High","gaps":["How a membrane-depleted mutant achieves MAPK activation mechanistically unclear","Direct ERK-activating substrate of mutant PKCα not defined"]},{"year":2022,"claim":"Connected PKCα to tumor immune evasion by direct phosphorylation of ZFP64-S226, driving CSF1 transcription and M2 macrophage polarization.","evidence":"MS phospho-site mapping, phospho-mutagenesis, nuclear translocation, ChIP, co-culture, orthotopic HCC xenograft","pmids":["35219791"],"confidence":"High","gaps":["Upstream signal activating PKCα in HCC not defined"]},{"year":null,"claim":"Open question: how the diverse PKCα substrate repertoire and scaffold-directed localizations are selected and integrated within a single cell, and whether a unifying logic governs which substrate is engaged under a given Ca2+/DAG stimulus.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated model of substrate-selection logic across tissues","Most substrate phosphorylations validated in single labs/contexts"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,6,12,15,16,18,28]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,16,18]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[15]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,10,11,14]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11,14]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,15]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,13,19,29]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,7,15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[21,22]},{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[0]}],"complexes":[],"partners":["ANXA6","RACK1","EGFR","ZFP64","GRASP55","CK1Δ","TRPC1","G3BP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P17252","full_name":"Protein kinase C alpha type","aliases":[],"length_aa":672,"mass_kda":76.8,"function":"Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231)","subcellular_location":"Cytoplasm; Cell membrane; Mitochondrion membrane; Nucleus","url":"https://www.uniprot.org/uniprotkb/P17252/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRKCA","classification":"Not Classified","n_dependent_lines":10,"n_total_lines":1208,"dependency_fraction":0.008278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PRKCA","total_profiled":1310},"omim":[{"mim_id":"616667","title":"SEZ6-LIKE PROTEIN 2; SEZ6L2","url":"https://www.omim.org/entry/616667"},{"mim_id":"616666","title":"SEIZURE-RELATED 6, MOUSE, HOMOLOG OF; SEZ6","url":"https://www.omim.org/entry/616666"},{"mim_id":"616297","title":"MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 2; MCTP2","url":"https://www.omim.org/entry/616297"},{"mim_id":"616296","title":"MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 1; MCTP1","url":"https://www.omim.org/entry/616296"},{"mim_id":"614959","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14; DEE14","url":"https://www.omim.org/entry/614959"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":32.9}],"url":"https://www.proteinatlas.org/search/PRKCA"},"hgnc":{"alias_symbol":["PKCα"],"prev_symbol":["PKCA"]},"alphafold":{"accession":"P17252","domains":[{"cath_id":"3.30.60.20","chopping":"30-154","consensus_level":"medium","plddt":87.5189,"start":30,"end":154},{"cath_id":"2.60.40.150","chopping":"160-294","consensus_level":"high","plddt":94.2672,"start":160,"end":294},{"cath_id":"3.30.200.20","chopping":"335-419_635-667","consensus_level":"high","plddt":89.7073,"start":335,"end":667},{"cath_id":"1.10.510.10","chopping":"424-606","consensus_level":"high","plddt":95.3708,"start":424,"end":606}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P17252","model_url":"https://alphafold.ebi.ac.uk/files/AF-P17252-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P17252-F1-predicted_aligned_error_v6.png","plddt_mean":86.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRKCA","jax_strain_url":"https://www.jax.org/strain/search?query=PRKCA"},"sequence":{"accession":"P17252","fasta_url":"https://rest.uniprot.org/uniprotkb/P17252.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P17252/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P17252"}},"corpus_meta":[{"pmid":"14966518","id":"PMC_14966518","title":"PKC-alpha regulates cardiac contractility and propensity toward heart failure.","date":"2004","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14966518","citation_count":491,"is_preprint":false},{"pmid":"35219791","id":"PMC_35219791","title":"PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.","date":"2022","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/35219791","citation_count":139,"is_preprint":false},{"pmid":"19147982","id":"PMC_19147982","title":"PKCalpha regulates platelet granule secretion and thrombus formation in mice.","date":"2009","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/19147982","citation_count":130,"is_preprint":false},{"pmid":"24401212","id":"PMC_24401212","title":"Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition.","date":"2013","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/24401212","citation_count":112,"is_preprint":false},{"pmid":"12972622","id":"PMC_12972622","title":"Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12972622","citation_count":105,"is_preprint":false},{"pmid":"20398285","id":"PMC_20398285","title":"PKCalpha expression is a marker for breast cancer aggressiveness.","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20398285","citation_count":93,"is_preprint":false},{"pmid":"35917680","id":"PMC_35917680","title":"TRPM7 channel inhibition attenuates rheumatoid arthritis articular chondrocyte ferroptosis by suppression of the PKCα-NOX4 axis.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35917680","citation_count":88,"is_preprint":false},{"pmid":"28751441","id":"PMC_28751441","title":"miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.","date":"2017","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/28751441","citation_count":86,"is_preprint":false},{"pmid":"24040137","id":"PMC_24040137","title":"miR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKCα.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24040137","citation_count":82,"is_preprint":false},{"pmid":"34419228","id":"PMC_34419228","title":"Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling.","date":"2021","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/34419228","citation_count":81,"is_preprint":false},{"pmid":"28796000","id":"PMC_28796000","title":"Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes.","date":"2017","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28796000","citation_count":79,"is_preprint":false},{"pmid":"26234676","id":"PMC_26234676","title":"TRM6/61 connects PKCα with translational control through tRNAi(Met) stabilization: impact on tumorigenesis.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26234676","citation_count":77,"is_preprint":false},{"pmid":"18323518","id":"PMC_18323518","title":"Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells.","date":"2008","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18323518","citation_count":69,"is_preprint":false},{"pmid":"22797061","id":"PMC_22797061","title":"Annexin A6 is a scaffold for PKCα to promote EGFR inactivation.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22797061","citation_count":68,"is_preprint":false},{"pmid":"17553429","id":"PMC_17553429","title":"Light entrainment of the mammalian circadian clock by a PRKCA-dependent posttranslational mechanism.","date":"2007","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17553429","citation_count":67,"is_preprint":false},{"pmid":"35013120","id":"PMC_35013120","title":"ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35013120","citation_count":66,"is_preprint":false},{"pmid":"29476136","id":"PMC_29476136","title":"A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29476136","citation_count":59,"is_preprint":false},{"pmid":"22725730","id":"PMC_22725730","title":"Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor.","date":"2012","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/22725730","citation_count":59,"is_preprint":false},{"pmid":"19576566","id":"PMC_19576566","title":"PRKCA: a positional candidate gene for body mass index and asthma.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19576566","citation_count":56,"is_preprint":false},{"pmid":"15585319","id":"PMC_15585319","title":"The link between PKCalpha regulation and cellular transformation.","date":"2005","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15585319","citation_count":56,"is_preprint":false},{"pmid":"9008415","id":"PMC_9008415","title":"PKC--a pivotal regulator of early development.","date":"1997","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9008415","citation_count":55,"is_preprint":false},{"pmid":"34040072","id":"PMC_34040072","title":"EGCG promotes PRKCA expression to alleviate LPS-induced acute lung injury and inflammatory response.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34040072","citation_count":53,"is_preprint":false},{"pmid":"33684690","id":"PMC_33684690","title":"Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.","date":"2021","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/33684690","citation_count":51,"is_preprint":false},{"pmid":"16479073","id":"PMC_16479073","title":"Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK.","date":"2006","source":"Journal of Korean medical science","url":"https://pubmed.ncbi.nlm.nih.gov/16479073","citation_count":51,"is_preprint":false},{"pmid":"29915258","id":"PMC_29915258","title":"A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29915258","citation_count":49,"is_preprint":false},{"pmid":"26295576","id":"PMC_26295576","title":"The Aspergillus fumigatus pkcA G579R Mutant Is Defective in the Activation of the Cell Wall Integrity Pathway but Is Dispensable for Virulence in a Neutropenic Mouse Infection Model.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26295576","citation_count":49,"is_preprint":false},{"pmid":"16297876","id":"PMC_16297876","title":"PKCalpha expression regulated by Elk-1 and MZF-1 in human HCC cells.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16297876","citation_count":48,"is_preprint":false},{"pmid":"17118679","id":"PMC_17118679","title":"The protein kinase C orthologue PkcA plays a role in cell wall integrity and polarized growth in Aspergillus nidulans.","date":"2006","source":"Fungal genetics and biology : FG & B","url":"https://pubmed.ncbi.nlm.nih.gov/17118679","citation_count":47,"is_preprint":false},{"pmid":"20444294","id":"PMC_20444294","title":"PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.","date":"2010","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/20444294","citation_count":47,"is_preprint":false},{"pmid":"21998327","id":"PMC_21998327","title":"Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury.","date":"2011","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/21998327","citation_count":47,"is_preprint":false},{"pmid":"22536444","id":"PMC_22536444","title":"PKCα binds G3BP2 and regulates stress granule formation following cellular stress.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22536444","citation_count":46,"is_preprint":false},{"pmid":"26763440","id":"PMC_26763440","title":"Keratin Isotypes Control Desmosome Stability and Dynamics through PKCα.","date":"2016","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/26763440","citation_count":45,"is_preprint":false},{"pmid":"26671581","id":"PMC_26671581","title":"Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.","date":"2015","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/26671581","citation_count":44,"is_preprint":false},{"pmid":"30759284","id":"PMC_30759284","title":"Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.","date":"2019","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/30759284","citation_count":44,"is_preprint":false},{"pmid":"12435334","id":"PMC_12435334","title":"Activation of Integrin-RACK1/PKCalpha signalling in human articular chondrocyte mechanotransduction.","date":"2002","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/12435334","citation_count":43,"is_preprint":false},{"pmid":"31207271","id":"PMC_31207271","title":"Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy.","date":"2019","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31207271","citation_count":42,"is_preprint":false},{"pmid":"16598003","id":"PMC_16598003","title":"Protein kinase C (PkcA) of Aspergillus nidulans is involved in penicillin production.","date":"2006","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16598003","citation_count":41,"is_preprint":false},{"pmid":"17986778","id":"PMC_17986778","title":"A protein kinase C-encoding gene, pkcA, is essential to the viability of the filamentous fungus Aspergillus nidulans.","date":"2007","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17986778","citation_count":39,"is_preprint":false},{"pmid":"16596167","id":"PMC_16596167","title":"PRKCA and multiple sclerosis: association in two independent populations.","date":"2006","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16596167","citation_count":39,"is_preprint":false},{"pmid":"33307285","id":"PMC_33307285","title":"The complexities of PKCα signaling in cancer.","date":"2020","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/33307285","citation_count":38,"is_preprint":false},{"pmid":"28629334","id":"PMC_28629334","title":"Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.","date":"2017","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28629334","citation_count":37,"is_preprint":false},{"pmid":"23290522","id":"PMC_23290522","title":"The kinase PKCα selectively upregulates interleukin-17A during Th17 cell immune responses.","date":"2013","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23290522","citation_count":36,"is_preprint":false},{"pmid":"25080502","id":"PMC_25080502","title":"Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25080502","citation_count":35,"is_preprint":false},{"pmid":"17406869","id":"PMC_17406869","title":"The Aspergillus nidulans pkcA gene is involved in polarized growth, morphogenesis and maintenance of cell wall integrity.","date":"2007","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17406869","citation_count":35,"is_preprint":false},{"pmid":"15155525","id":"PMC_15155525","title":"Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population.","date":"2004","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15155525","citation_count":34,"is_preprint":false},{"pmid":"20951242","id":"PMC_20951242","title":"PKCα suppresses osteoblastic differentiation.","date":"2010","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/20951242","citation_count":34,"is_preprint":false},{"pmid":"32179476","id":"PMC_32179476","title":"Cytosolic Ca2+ Modulates Golgi Structure Through PKCα-Mediated GRASP55 Phosphorylation.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32179476","citation_count":34,"is_preprint":false},{"pmid":"23908466","id":"PMC_23908466","title":"Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23908466","citation_count":34,"is_preprint":false},{"pmid":"26676968","id":"PMC_26676968","title":"Pigment-Synthesizing Melanocytic Neoplasm With Protein Kinase C Alpha (PRKCA) Fusion.","date":"2016","source":"JAMA dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/26676968","citation_count":33,"is_preprint":false},{"pmid":"21906873","id":"PMC_21906873","title":"Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21906873","citation_count":33,"is_preprint":false},{"pmid":"21642422","id":"PMC_21642422","title":"Receptor-independent protein kinase C alpha (PKCalpha) signaling by calpain-generated free catalytic domains induces HDAC5 nuclear export and regulates cardiac transcription.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21642422","citation_count":33,"is_preprint":false},{"pmid":"15365248","id":"PMC_15365248","title":"PKCalpha induces differentiation through ERK1/2 phosphorylation in mouse keratinocytes.","date":"2004","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15365248","citation_count":33,"is_preprint":false},{"pmid":"8569684","id":"PMC_8569684","title":"Cloning and characterisation of genes (pkc1 and pkcA) encoding protein kinase C homologues from Trichoderma reesei and Aspergillus niger.","date":"1996","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/8569684","citation_count":32,"is_preprint":false},{"pmid":"15057036","id":"PMC_15057036","title":"The role of protein kinase C-alpha (PKC-alpha) in melanoma.","date":"2004","source":"Melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/15057036","citation_count":32,"is_preprint":false},{"pmid":"28028127","id":"PMC_28028127","title":"Myofibrillar Z-discs Are a Protein Phosphorylation Hot Spot with Protein Kinase C (PKCα) Modulating Protein Dynamics.","date":"2016","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/28028127","citation_count":31,"is_preprint":false},{"pmid":"36448837","id":"PMC_36448837","title":"PRKCA Promotes Mitophagy through the miR-15a-5p/PDK4 Axis to Relieve Sepsis-Induced Acute Lung Injury.","date":"2022","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/36448837","citation_count":30,"is_preprint":false},{"pmid":"27876854","id":"PMC_27876854","title":"miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27876854","citation_count":30,"is_preprint":false},{"pmid":"33742095","id":"PMC_33742095","title":"Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.","date":"2021","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/33742095","citation_count":29,"is_preprint":false},{"pmid":"32019972","id":"PMC_32019972","title":"Rac1 is a downstream effector of PKCα in structural synaptic plasticity.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32019972","citation_count":29,"is_preprint":false},{"pmid":"29319178","id":"PMC_29319178","title":"Glucose enhances aggrecan expression in chondrocytes via the PKCα/p38-miR141-3p signaling pathway.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29319178","citation_count":28,"is_preprint":false},{"pmid":"34174172","id":"PMC_34174172","title":"Extracellular Matrix Stiffness Regulates DNA Methylation by PKCα-Dependent Nuclear Transport of DNMT3L.","date":"2021","source":"Advanced healthcare materials","url":"https://pubmed.ncbi.nlm.nih.gov/34174172","citation_count":27,"is_preprint":false},{"pmid":"32958674","id":"PMC_32958674","title":"Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32958674","citation_count":27,"is_preprint":false},{"pmid":"26542395","id":"PMC_26542395","title":"PKCα regulates TMEM16A-mediated Cl⁻ secretion in human biliary cells.","date":"2015","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26542395","citation_count":27,"is_preprint":false},{"pmid":"28125719","id":"PMC_28125719","title":"Toxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCα.","date":"2017","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/28125719","citation_count":27,"is_preprint":false},{"pmid":"25070889","id":"PMC_25070889","title":"Protein kinase Cα (PKCα) regulates bone architecture and osteoblast activity.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25070889","citation_count":26,"is_preprint":false},{"pmid":"30463939","id":"PMC_30463939","title":"Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30463939","citation_count":26,"is_preprint":false},{"pmid":"27696692","id":"PMC_27696692","title":"Gene-Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril.","date":"2016","source":"Basic & clinical pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/27696692","citation_count":25,"is_preprint":false},{"pmid":"31119784","id":"PMC_31119784","title":"miR-216a promotes breast cancer cell apoptosis by targeting PKCα.","date":"2019","source":"Fundamental & clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31119784","citation_count":25,"is_preprint":false},{"pmid":"23656785","id":"PMC_23656785","title":"K562 cell proliferation is modulated by PLCβ1 through a PKCα-mediated pathway.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23656785","citation_count":25,"is_preprint":false},{"pmid":"28402280","id":"PMC_28402280","title":"Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28402280","citation_count":24,"is_preprint":false},{"pmid":"25391900","id":"PMC_25391900","title":"PKC-α contributes to high NaCl-induced activation of NFAT5 (TonEBP/OREBP) through MAPK ERK1/2.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25391900","citation_count":24,"is_preprint":false},{"pmid":"20938215","id":"PMC_20938215","title":"Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.","date":"2010","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20938215","citation_count":24,"is_preprint":false},{"pmid":"32511969","id":"PMC_32511969","title":"Glucose fluctuations promote vascular BK channels dysfunction via PKCα/NF-κB/MuRF1 signaling.","date":"2020","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/32511969","citation_count":22,"is_preprint":false},{"pmid":"29752438","id":"PMC_29752438","title":"Role of FGFR2b expression and signaling in keratinocyte differentiation: sequential involvement of PKCδ and PKCα.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29752438","citation_count":22,"is_preprint":false},{"pmid":"25514083","id":"PMC_25514083","title":"PKCα and PKCδ activation regulates transcriptional activity and degradation of progesterone receptor in human astrocytoma cells.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25514083","citation_count":22,"is_preprint":false},{"pmid":"30423260","id":"PMC_30423260","title":"Hyperglycemia promotes microvillus membrane expression of DMT1 in intestinal epithelial cells in a PKCα-dependent manner.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30423260","citation_count":22,"is_preprint":false},{"pmid":"35760100","id":"PMC_35760100","title":"PKCα and PKCδ: Friends and Rivals.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35760100","citation_count":21,"is_preprint":false},{"pmid":"32420639","id":"PMC_32420639","title":"The P2Y6 receptor signals through Gαq /Ca2+ /PKCα and Gα13 /ROCK pathways to drive the formation of membrane protrusions and dictate cell migration.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32420639","citation_count":21,"is_preprint":false},{"pmid":"19235902","id":"PMC_19235902","title":"Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.","date":"2009","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19235902","citation_count":21,"is_preprint":false},{"pmid":"32638182","id":"PMC_32638182","title":"The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis.","date":"2020","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/32638182","citation_count":20,"is_preprint":false},{"pmid":"26260115","id":"PMC_26260115","title":"SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors.","date":"2015","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/26260115","citation_count":19,"is_preprint":false},{"pmid":"27576187","id":"PMC_27576187","title":"Distinctive and selective route of PI3K/PKCα-PKCδ/RhoA-Rac1 signaling in osteoclastic cell migration.","date":"2016","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27576187","citation_count":19,"is_preprint":false},{"pmid":"26803658","id":"PMC_26803658","title":"CK1δ kinase activity is modulated by protein kinase C α (PKCα)-mediated site-specific phosphorylation.","date":"2016","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/26803658","citation_count":18,"is_preprint":false},{"pmid":"30230261","id":"PMC_30230261","title":"PKCα replaces AMPK to regulate mitophagy: Another PEDF role on ischaemic cardioprotection.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30230261","citation_count":18,"is_preprint":false},{"pmid":"27198223","id":"PMC_27198223","title":"PKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27198223","citation_count":18,"is_preprint":false},{"pmid":"31806641","id":"PMC_31806641","title":"Cooperative Blockade of PKCα and JAK2 Drives Apoptosis in Glioblastoma.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31806641","citation_count":17,"is_preprint":false},{"pmid":"30849522","id":"PMC_30849522","title":"LPA1 receptor activation induces PKCα nuclear translocation in glioblastoma cells.","date":"2019","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30849522","citation_count":16,"is_preprint":false},{"pmid":"26056003","id":"PMC_26056003","title":"PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26056003","citation_count":16,"is_preprint":false},{"pmid":"33250241","id":"PMC_33250241","title":"PKCα mediated by the PI3K/Akt-FOXA1 cascade facilitates cypermethrin-induced hyperthyroidism.","date":"2020","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/33250241","citation_count":16,"is_preprint":false},{"pmid":"22773839","id":"PMC_22773839","title":"Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22773839","citation_count":16,"is_preprint":false},{"pmid":"30422318","id":"PMC_30422318","title":"Let-7g-5p regulates mouse mammary cells differentiation and function by targeting PRKCA.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30422318","citation_count":15,"is_preprint":false},{"pmid":"32084499","id":"PMC_32084499","title":"miR-709 inhibits GHRP6 induced GH synthesis by targeting PRKCA in pituitary.","date":"2020","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32084499","citation_count":15,"is_preprint":false},{"pmid":"30604284","id":"PMC_30604284","title":"Differential expression of PKCα and -β in the zebrafish retina.","date":"2019","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30604284","citation_count":15,"is_preprint":false},{"pmid":"33785524","id":"PMC_33785524","title":"The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC.","date":"2021","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/33785524","citation_count":15,"is_preprint":false},{"pmid":"31094294","id":"PMC_31094294","title":"PKCα promotes insulin secretion via TRPC1 phosphorylation in INS-1E cells.","date":"2019","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31094294","citation_count":15,"is_preprint":false},{"pmid":"17007817","id":"PMC_17007817","title":"Polycystin-1 promotes PKCalpha-mediated NF-kappaB activation in kidney cells.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17007817","citation_count":15,"is_preprint":false},{"pmid":"37528485","id":"PMC_37528485","title":"SUMOylation of AnxA6 facilitates EGFR-PKCα complex formation to suppress epithelial cancer growth.","date":"2023","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/37528485","citation_count":14,"is_preprint":false},{"pmid":"33916643","id":"PMC_33916643","title":"LPA1 Receptor Promotes Progesterone Receptor Phosphorylation through PKCα in Human Glioblastoma Cells.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33916643","citation_count":14,"is_preprint":false},{"pmid":"37390986","id":"PMC_37390986","title":"Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37390986","citation_count":14,"is_preprint":false},{"pmid":"25006961","id":"PMC_25006961","title":"Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25006961","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51205,"output_tokens":10425,"usd":0.154995,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21867,"output_tokens":3466,"usd":0.097992,"stage2_stop_reason":"end_turn"},"total_usd":0.252987,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"PKCα directly phosphorylates protein phosphatase inhibitor-1 (I-1), thereby altering the activity of protein phosphatase-1 (PP-1), which in turn affects dephosphorylation of the SERCA-2 inhibitory protein phospholamban (PLB), modulating sarcoplasmic reticulum Ca2+ loading and the Ca2+ transient in cardiac myocytes. Loss of Prkca in mice produces hypercontractile hearts; overexpression produces hypocontractile hearts.\",\n      \"method\": \"Prkca knockout mice, cardiac-specific transgenic overexpression, adenoviral dominant-negative/wild-type gene transfer into cardiomyocytes, biochemical phosphorylation assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vivo genetic models (KO and transgenic), adenoviral rescue, direct biochemical substrate identification, replicated across several cardiac disease models\",\n      \"pmids\": [\"14966518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PKCα is required for dense-granule biogenesis and secretion in platelets; Prkca−/− mice show attenuated thrombus formation in vivo and defective platelet aggregation in vitro that can be rescued by exogenous ADP, placing PKCα upstream of dense-granule secretion and thrombus formation.\",\n      \"method\": \"Prkca knockout mice, in vivo thrombosis model, in vitro platelet aggregation and secretion assays, ADP rescue experiment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple orthogonal functional assays (in vivo thrombosis, in vitro aggregation, granule secretion) and mechanistic rescue\",\n      \"pmids\": [\"19147982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PKCα acts upstream of PKCθ to activate the IKK complex and NF-κB–dependent transcription following TCR/CD28 co-stimulation. An early phase (1–5 min) of IKK activation is PKCα-dependent and requires Ca2+-binding residues D246/D248 for membrane recruitment; a later phase (5–25 min) is PKCθ-dependent. Catalytically active PKCαA25E drives NF-κB transcription, and this is abrogated by kinase-inactive PKCθ.\",\n      \"method\": \"Genetic analysis (dominant-negative/constitutively active constructs), pharmacological inhibition, RNA interference, kinetic IKK activation assays in T lymphocytes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis established by multiple complementary approaches (RNAi, pharmacological inhibition, mutagenesis of Ca2+-binding residues, kinetic analysis)\",\n      \"pmids\": [\"12972622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Light exposure in the SCN evokes a transient interaction between PRKCA and PERIOD 2 (PER2) protein that affects PER2 stability and nucleocytoplasmic distribution; Prkca-deficient mice show impaired light-mediated circadian clock resetting, identifying PKCα as a component of a posttranslational photic input pathway.\",\n      \"method\": \"Prkca knockout mice, behavioral circadian assays, co-immunoprecipitation of PRKCA–PER2 interaction in SCN, subcellular fractionation of PER2\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO phenotype combined with direct protein interaction and localization data in relevant tissue\",\n      \"pmids\": [\"17553429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Calpain-mediated proteolytic processing of PKCα in ischemic myocardium releases a constitutively active free catalytic fragment (PKCα-CT) that localizes to nuclei, directly promotes HDAC5 nucleo-cytoplasmic shuttling independently of PKD, and induces MEF2-dependent pathological cardiac gene expression.\",\n      \"method\": \"Expression of PKCα-CT in cardiomyocytes, nuclear fractionation, HDAC5 localization assays, comparison with phorbol ester-activated full-length PKCα requiring PKD\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic distinction from full-length PKCα established with subcellular localization and gene expression readouts in a single lab\",\n      \"pmids\": [\"21642422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKCα directly binds and phosphorylates G3BP2 via its regulatory domain interacting with the C-terminal RNA-binding domain of G3BP2; both proteins co-localize in stress granules (but not P-bodies) upon stress, and PKCα knockdown suppresses heat-shock-induced stress granule assembly and eIF2α phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, RNase-resistance assay, in vitro kinase assay with recombinant proteins, siRNA knockdown, live-cell imaging of stress granule formation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro phosphorylation with recombinant proteins, domain-mapping, functional KD phenotype in single lab with multiple orthogonal methods\",\n      \"pmids\": [\"22536444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Annexin A6 (AnxA6) acts as a scaffold that recruits PKCα to the plasma membrane, facilitating PKCα-mediated phosphorylation of EGFR at T654, inhibiting EGFR tyrosine phosphorylation and downstream activation. AnxA6 N-terminal mutant unable to recruit PKCα to the membrane fails to increase T654-EGFR phosphorylation; the T654A EGFR mutant is not inhibited by AnxA6 overexpression.\",\n      \"method\": \"Ectopic AnxA6 expression, PKCα siRNA knockdown, AnxA6(1-175) cytosolic mutant and plasma-membrane-anchored AnxA6, T654A EGFR mutant, Co-IP of AnxA6–EGFR–PKCα complex\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple gain/loss-of-function constructs, domain mutants, substrate phospho-site mutant, and complex Co-IP in a single rigorous study\",\n      \"pmids\": [\"22797061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PKCα physically interacts and functionally cooperates with TGFβRI to promote robust SMAD2/3 activation, selectively upregulating IL-17A (but not IL-17F) in Th17 cells. Prkca−/− cells show defective SMAD-dependent IL-2 suppression and decreased STAT3 DNA binding at the Il17a promoter, and are resistant to Th17-cell-dependent EAE.\",\n      \"method\": \"Prkca knockout mice, Co-IP of PKCα–TGFβRI interaction, SMAD2/3 phosphorylation assays, STAT3 ChIP, in vivo EAE model\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO, direct interaction by Co-IP, multiple downstream signaling readouts, in vivo disease model\",\n      \"pmids\": [\"23290522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PKCα interacts with TRM61, the catalytic subunit of the TRM6/61 tRNA methyltransferase complex. Elevated TRM6/61 increases translation of tumorigenic mRNAs via tRNAiMet stabilization, and PKCα overexpression in TRM6/61-overexpressing cells decreases tRNAiMet expression and tumorigenic colony/sphere formation, indicating PKCα controls TRM6/61 activity to prevent translational deregulation.\",\n      \"method\": \"Co-immunoprecipitation of PKCα–TRM61, tRNAiMet expression assays, colony and sphere formation assays with PKCα overexpression vs. TRM6/61 overexpression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and functional rescue in a single lab; mechanistic link to translational control supported by multiple assays\",\n      \"pmids\": [\"26234676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKCα knockdown in endothelial cells increases VEGFR2 tyrosine phosphorylation, protein and mRNA expression, and enhances VEGF-stimulated Akt/eNOS phosphorylation, demonstrating that PKCα negatively regulates VEGFR2 expression and VEGF signaling (opposite to PKCε which positively regulates VEGFR2).\",\n      \"method\": \"siRNA knockdown of PKCα (and PKCε/δ for comparison), VEGFR2 phosphorylation and expression assays, Akt/eNOS phosphorylation, DNA synthesis assay\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-selective siRNA with multiple downstream readouts in a single lab\",\n      \"pmids\": [\"18323518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mechanical stimulation of human articular chondrocytes induces rapid β1 integrin–dependent translocation of PKCα to the cell membrane and increased association of the scaffolding protein RACK1 with both PKCα and β1 integrin, placing RACK1 as a mechanotransduction intermediary for PKCα membrane recruitment.\",\n      \"method\": \"Mechanical stimulation of chondrocytes, anti-integrin antibody blocking, subcellular fractionation, Co-IP of RACK1–PKCα–β1 integrin\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with integrin-blocking functional link, single lab\",\n      \"pmids\": [\"12435334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"K5/K14 keratins sequester PKCα in the cytoplasm, whereas wound-healing keratins K6/K17 enable PKCα translocation to the plasma membrane, promoting PKCα-mediated desmosome disassembly. Gain- and loss-of-function of K5 modulates desmosome stability via PKCα.\",\n      \"method\": \"Stable re-expression of keratin isotypes in keratin-null keratinocytes, live-cell imaging of PKCα localization, desmosome stability/adhesion assays, PKCα gain/loss-of-function\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — controlled genetic system with multiple functional assays, single lab\",\n      \"pmids\": [\"26763440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Elevated cytosolic Ca2+ activates PKCα, which phosphorylates the Golgi stacking protein GRASP55, causing Golgi fragmentation. PKCα activation by PMA or histamine also modulates Golgi structure in the same manner; this pathway operates independently of ER stress.\",\n      \"method\": \"Thapsigargin/PMA/histamine treatment of HeLa cells, PKCα activity inhibition, GRASP55 phosphorylation assays, Golgi morphology imaging\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct substrate phosphorylation (GRASP55) with pharmacological PKCα inhibition and multiple activating stimuli, single lab\",\n      \"pmids\": [\"32179476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKCα overexpression in undifferentiated mouse keratinocytes induces differentiation markers (loricrin, filaggrin, K1, K10) and ERK1/2 phosphorylation without affecting p38 or JNK; dominant-negative PKCα blocks Ca2+-mediated differentiation markers; MEK inhibition blocks PKCα-mediated differentiation, placing PKCα→ERK1/2 as the specific pathway for PKCα-driven keratinocyte differentiation.\",\n      \"method\": \"Adenoviral overexpression and dominant-negative PKCα in keratinocytes, differentiation marker assays, MEK/p38/JNK inhibitors, ERK1/2 dominant-negative constructs\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain/loss-of-function with isoform-specific dominants and pathway inhibitors in a single lab\",\n      \"pmids\": [\"15365248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PKCα regulates TMEM16A-mediated Cl− secretion in biliary epithelial cells: extracellular ATP induces PKCα translocation from cytosol to plasma membrane; intracellular dialysis with recombinant PKCα activates Cl− currents indistinguishable from TMEM16A; these currents are absent after TMEM16A siRNA, demonstrating direct functional coupling of PKCα to TMEM16A.\",\n      \"method\": \"Whole-cell patch-clamp, intracellular dialysis with recombinant PKCα, PKCα siRNA, TMEM16A siRNA, subcellular fractionation\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with recombinant protein (intracellular dialysis) combined with siRNA knockdown and electrophysiology in single lab\",\n      \"pmids\": [\"26542395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PKCα directly phosphorylates ZFP64 at S226, leading to its nuclear translocation and transcriptional activation of CSF1, which transforms macrophages toward M2 polarization to drive immune evasion and anti-PD1 resistance in hepatocellular carcinoma.\",\n      \"method\": \"Mass spectrometry, phospho-site mutagenesis, nuclear translocation assays, chromatin immunoprecipitation, in vitro co-culture, orthotopic HCC xenograft model\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct phosphorylation site identified by MS, validated by mutagenesis, ChIP, and in vivo model in a single comprehensive study\",\n      \"pmids\": [\"35219791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PKCα phosphorylates CK1δ at C-terminal residues S328, T329, and S370 in vitro; mutation of these sites dramatically alters CK1δ kinetic parameters; pharmacological PKCα inhibition in cells reduces CK1δ activity, demonstrating that PKCα is a regulator of CK1δ kinase activity.\",\n      \"method\": \"In vitro kinase assay (PKCα phosphorylating CK1δ), site-directed mutagenesis of CK1δ phospho-sites, Go-6983 PKCα inhibitor in cell culture, kinetic analysis\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and cellular validation, single lab\",\n      \"pmids\": [\"26803658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PKCα interacts with ULK1 through the ULK1 serine/threonine-rich (S/T) domain; phospho-PKCα phosphorylates ULK1 at Ser317/555/777 and Raptor, promoting mitophagy and replacing AMPK-dependent mitophagy during PEDF-induced cardioprotection in OGD cardiomyocytes. A ULK1 deletion mutant lacking the S/T domain fails to mediate PEDF-induced mitophagy.\",\n      \"method\": \"Co-IP of PKCα–ULK1 interaction, deletion mutagenesis of ULK1, phosphorylation assays, mitophagy markers, OGD cardiomyocyte model\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction by Co-IP with domain mapping and phospho-site identification, single lab\",\n      \"pmids\": [\"30230261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PKCα phosphorylates filamin C (FLNc) at distinct serine residues in its hinge 2 region, preventing calpain 1 cleavage at an adjacent tyrosine. FRAP analysis shows this phosphorylation modulates FLNc dynamics at Z-discs in contracting skeletal myotubes.\",\n      \"method\": \"Quantitative phosphoproteomics of Z-disc in electrically stimulated myotubes, in vitro PKCα phosphorylation assay, FRAP, FLNc cleavage assays\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay, FRAP functional validation, and phosphoproteomics in a single rigorous study\",\n      \"pmids\": [\"28028127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PKCα positively regulates Rac1 activation during single-spine structural plasticity in dendritic spines; removal of PKCα expression attenuates Rac1 (but not Ras or Cdc42) activation. Disruption of a PDZ binding domain within PKCα impairs Rac1 activation and structural spine remodeling, positioning PKCα upstream of Rac1 in actin-dependent synaptic plasticity.\",\n      \"method\": \"PKCα knockdown/knockout in postsynaptic spines, FRET-based biosensors for Rac1/Cdc42/Ras activity during single-spine structural plasticity, PDZ domain mutant of PKCα\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific KO with live biosensor imaging and domain-mutant, single lab\",\n      \"pmids\": [\"32019972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Pharmacological inhibition of PKCα/β with ruboxistaurin in a pig model of myocardial infarction-induced heart failure improves contractility, ejection fraction, and cardiac output, extending the mouse/rat cardiac contractility findings to a large-animal model.\",\n      \"method\": \"Left anterior descending artery occlusion in pigs, ruboxistaurin oral administration, echocardiographic measurements over 3 months\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition in large-animal model, single lab, extends earlier mechanistic findings\",\n      \"pmids\": [\"21998327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The recurrent PRKCA D463H kinase-domain mutation found in all chordoid gliomas is a gain-of-function mutation; expression of mutant PRKCA in immortalized astrocytes increases phospho-ERK and anchorage-independent growth that is blocked by MEK inhibition, implicating the MAPK pathway downstream of mutant PKCα.\",\n      \"method\": \"Genomic sequencing of 13 chordoid gliomas, expression of PRKCA D463H in immortalized astrocytes, phospho-ERK assays, MEK inhibitor treatment, soft-agar colony formation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — recurrent mutation identified by sequencing, functional gain-of-function validated in cell model with signaling and MEK inhibitor rescue, replicated in two independent studies (PMIDs 29476136 and 29915258)\",\n      \"pmids\": [\"29476136\", \"29915258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The PKCα D463H mutant protein is depleted from the cell membrane compared to wild-type PKCα, is less stable, and its mRNA is more abundant than wild-type, with enriched activation of the EIF2 translation-initiation pathway. The mutant enhances proliferation of astrocytes and tanycytes.\",\n      \"method\": \"Whole-exome and RNA-sequencing of ChG, subcellular fractionation of PKCαD463H vs WT, protein stability assays, pathway activation analysis, proliferation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization/stability comparisons of mutant vs WT protein in single study\",\n      \"pmids\": [\"29915258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PKCα promotes ROS production in hepatocellular carcinoma cells by upregulating DUOX2 at the post-transcriptional level; depletion of DUOX2 abrogates PKCα-induced AKT/MAPK pathway activation and cell proliferation, migration, and invasion.\",\n      \"method\": \"PKCα overexpression/knockdown in HCC cells, DUOX2 knockdown, ROS measurement, AKT/MAPK phosphorylation assays, proliferation/migration/invasion assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistatic ordering of PKCα→DUOX2→AKT/MAPK with KO/KD functional readouts, single lab\",\n      \"pmids\": [\"26056003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ECM stiffness activates PKCα which promotes nuclear transport of DNMT3L; stiff ECM leads to global hypermethylation (particularly at pluripotent gene promoters) in a PKCα-dependent manner. DNMT3L binds the Nanog promoter during cell–ECM interactions.\",\n      \"method\": \"Polyacrylamide gel substrates of varying stiffness, PKCα inhibition/knockdown, DNMT3L nuclear fractionation, methylation assays, ChIP of DNMT3L at Nanog promoter\",\n      \"journal\": \"Advanced healthcare materials\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PKCα-dependent nuclear transport with functional epigenetic readout, single lab\",\n      \"pmids\": [\"34174172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKCα and PKCδ phosphorylate the progesterone receptor (PR) at Ser400 within minutes of PKC activation, inducing PR transcriptional activity and subsequent proteasomal degradation. PR directly associates with PKCα (maximally at 5 min post-TPA), and PR Ser400Ala mutant blocks PKC-mediated PR phosphorylation and degradation.\",\n      \"method\": \"TPA treatment, siRNA silencing and pharmacological inhibition of PKCα/PKCδ, Co-IP of PR–PKCα, immunofluorescence nuclear colocalization, PR S400A mutant, luciferase reporter, proteasome inhibitor\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction by Co-IP, phospho-site mutant validation, multiple functional readouts, single lab\",\n      \"pmids\": [\"25514083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"H2O2-induced poly-ADP-ribose (PAR) formation is mediated by the PLC/IP3R/Ca2+/PKCα signaling axis; PKCα knockdown completely abolishes PAR formation despite persistent DNA damage. Co-depletion of HMGB1 with PKCα restores PAR formation, indicating PKCα activation releases HMGB1-mediated inhibition of PAR synthesis.\",\n      \"method\": \"RPPA signaling analysis, PKCα siRNA, HMGB1 siRNA, Ca2+ chelation, PAR quantification, DNA damage markers\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistatic ordering with two co-depletion experiments and pathway pharmacology, single lab\",\n      \"pmids\": [\"27198223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PKCα-mediated phosphorylation of T. gondii GRA7 at Ser52 regulates interaction of GRA7 with the PYD domain of ASC to promote inflammasome activation; PKCα-mediated phosphorylation of GRA7 at Ser135 facilitates interaction with the PX domain of PLD1, enhancing its enzyme activity and phago-lysosomal maturation for antimycobacterial defense.\",\n      \"method\": \"Phospho-site mutagenesis of GRA7 Ser52/Ser135, Co-IP of GRA7–ASC and GRA7–PLD1, PLD1 enzyme activity assay, phagolysosomal fusion assays, mycobacterial killing assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-site mutagenesis combined with functional interaction and enzyme activity assays, single lab\",\n      \"pmids\": [\"28125719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKCα promotes insulin secretion in INS-1E cells by phosphorylating TRPC1; inhibition of PKCα reduces TRPC1 phosphorylation and intracellular Ca2+ levels, reducing insulin secretion; TRPC1 overexpression reverses the decrease in Ca2+ and insulin secretion caused by PKCα inhibition.\",\n      \"method\": \"PKCα activation/inhibition in INS-1E cells, TRPC1 phosphorylation assays, intracellular Ca2+ measurement, insulin secretion assay, TRPC1 overexpression rescue\",\n      \"journal\": \"Bioscience, biotechnology, and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct substrate phosphorylation and functional rescue, single lab\",\n      \"pmids\": [\"31094294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKCα contributes to high NaCl-induced NFAT5 activation through ERK1/2 but not through SHP-1-S591 phosphorylation; Prkca knockout reduces ERK1/2 phosphorylation and NFAT5 target gene expression in the renal inner medulla; combined knockdown of PKCα and ERK2 has no greater effect than either alone, placing them in the same pathway.\",\n      \"method\": \"Prkca knockout mice (renal medulla analysis), siRNA knockdown in HEK293 cells, NFAT5 transcriptional activity assay, ERK1/2 phosphorylation, SHP-1 phosphorylation assays\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO and siRNA epistasis with multiple signaling readouts, single lab\",\n      \"pmids\": [\"25391900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Polycystin-1 (PC1) cytoplasmic tail upregulates NF-κB nuclear levels and transcriptional activity in kidney cells through a PKCα-mediated mechanism; this anti-apoptotic pathway is blocked by the PKCα-specific inhibitor Ro-320432, and PC1-dependent antiapoptotic effects are reduced by PKC and NF-κB inhibitors.\",\n      \"method\": \"Stable expression of PC1 CTT in HEK293 cells, PKCα inhibitor Ro-320432, NF-κB luciferase reporter, apoptosis assays, RNA interference of endogenous PC1\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pharmacological inhibition with multiple functional readouts; PKCα specificity rests on a single inhibitor without direct PKCα activity measurement\",\n      \"pmids\": [\"17007817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gi/o GPCR activation drives tunneling nanotube (TNT) formation through a Gβγ→PLCβ3→PKCα signaling axis; PKCα-dependent phosphorylation of cofilin stabilizes actin in TNT structures. PKCα inhibition blocks TNT formation downstream of OXER1 and LPA receptors.\",\n      \"method\": \"Pertussis toxin treatment, PLCβ3 siRNA, PKCα inhibition/siRNA, cofilin phosphorylation assays, TNT quantification by microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway epistasis established by siRNA and pharmacological inhibition with structural and biochemical readouts, single lab\",\n      \"pmids\": [\"37390986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LDB3 mutation (Ala165Val) impairs PKCα signaling at the Z-disc in skeletal muscle by disrupting LDB3 interactions with filamin C, HSPA8, and PKCα, leading to protein aggregation and Z-disc disruption; this is linked to TSC2-mTOR downregulation as a parallel pathway.\",\n      \"method\": \"Ldb3Ala165Val/+ knock-in mice, Co-IP of LDB3–filamin C–HSPA8–PKCα complex, PKCα activity assays, mTOR pathway analysis, histology of Z-disc\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction data and knock-in model with functional readouts, single lab\",\n      \"pmids\": [\"33742095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PHF8 histone demethylase regulates PRKCA transcription by interacting with c-Jun on the PRKCA promoter; PKCα in turn activates Src, which destabilizes PTEN via the PKCα-Src axis in gastric cancer cells.\",\n      \"method\": \"ChIP of PHF8/c-Jun at PRKCA promoter, PHF8/PKCα knockdown and ectopic expression, Src activity and PTEN expression assays, zebrafish migration model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP at PRKCA promoter and epistatic rescue experiments, single lab\",\n      \"pmids\": [\"32958674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In female Prkca−/− mice, PKCα normally suppresses endosteal bone formation by inhibiting osteoblast differentiation and Wnt target gene expression; within osteoblastic cells PKCα enhances proliferation and suppresses differentiation via the Wnt pathway. Estradiol and mechanical strain stimulate WT but not Prkca−/− osteoblastic cell proliferation.\",\n      \"method\": \"Prkca knockout mice (bone phenotype), osteoblast differentiation markers, Wnt target gene expression, estradiol/mechanical strain stimulation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple cellular and molecular readouts in bone, single lab\",\n      \"pmids\": [\"25070889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TRPM7 channel activity elevates intracellular Ca2+ and drives chondrocyte ferroptosis via the PKCα–NOX4 axis; PKCα was shown to directly bind NOX4, and TRPM7 inhibition reduces this interaction. AAV9-mediated TRPM7 silencing and pharmacological TRPM7 blockade attenuate cartilage destruction in adjuvant arthritis rats.\",\n      \"method\": \"TRPM7 knockdown/pharmacological inhibition, Co-IP of PKCα–NOX4, intracellular Ca2+ measurement, ferroptosis markers, in vivo AA rat model with AAV9\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct PKCα–NOX4 interaction by Co-IP, in vivo genetic and pharmacological models, single lab\",\n      \"pmids\": [\"35917680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Absence of PKCα (Prkca KO) prevents lithium-induced downregulation of aquaporin-2 (AQP2) and urea transporter UT-A1 in renal inner medullary collecting duct cells, and attenuates lithium-induced nephrogenic diabetes insipidus (polyuria), indicating PKCα mediates lithium-induced dysregulation of these water/urea channels.\",\n      \"method\": \"Prkca knockout mice, lithium treatment (acute and chronic), Western blot for AQP2/UT-A1 in medullary tissue, urine output and osmolality measurements\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with direct protein expression and physiological readouts, single lab\",\n      \"pmids\": [\"25006961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Inhibition of ezrin disrupts the HER2–PMCA2–NHERF1–HSP90 membrane complex and causes PKCα-mediated internalization and degradation of HER2; inhibition of ezrin synergizes with lapatinib in a PKCα-dependent fashion to reduce proliferation and promote apoptosis in HER2-positive breast cancer cells.\",\n      \"method\": \"Ezrin knockdown/pharmacological inhibition, Co-IP of HER2–PMCA2–NHERF1–HSP90–ezrin complex, HER2 membrane retention assays, PKCα inhibition rescue, proliferation/apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP complex disruption with PKCα-dependent functional rescue, single lab\",\n      \"pmids\": [\"30463939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PKCα suppresses osteoblastic differentiation (ALP activity, ALP/osteocalcin gene expression) but promotes osteoblastic cell proliferation; siRNA knockdown of PKCα increases differentiation markers, while wild-type PKCα overexpression decreases them in MC3T3-E1 cells.\",\n      \"method\": \"Gö6976 inhibitor, PKCα siRNA knockdown, wild-type PKCα overexpression, ALP activity assay, gene expression analysis\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition, siRNA KD, and overexpression with multiple differentiation readouts, single lab\",\n      \"pmids\": [\"20951242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Integrin αv upregulates PKCα expression in a 3D collagen microenvironment; PKCα promotes cytoplasmic relocalization of p53 from the nucleus, suppressing p53 activity and promoting melanoma cell survival; stable knockdown of PKCα inhibits integrin αv-mediated p53 relocalization and promotes apoptosis in 3D collagen and in vivo.\",\n      \"method\": \"Microarray (integrin αv KD), stable PKCα knockdown, p53 subcellular fractionation in 3D collagen and in vivo, apoptosis assays, tumor xenograft\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — stable KD with in vivo validation and direct localization readout, single lab\",\n      \"pmids\": [\"22773839\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PKCα (PRKCA) is a Ca2+- and diacylglycerol-activated serine/threonine kinase that operates as a nodal signaling integrator: it phosphorylates diverse substrates including inhibitor-1 (I-1, regulating PP-1/phospholamban/cardiac contractility), EGFR-T654 (via AnxA6 scaffolding to inactivate EGFR), ZFP64-S226 (driving CSF1 transcription and immune evasion), GRASP55 (modulating Golgi structure in response to Ca2+), filamin C hinge-2 serines (preventing calpain cleavage at Z-discs), CK1δ C-terminal serines (altering CK1δ activity), TRPC1 (promoting insulin secretion), and GRA7 (regulating inflammasome and phagolysosomal defense); it also acts as an upstream activator of IKK/NF-κB (via PKCθ in T cells), ERK1/2, Rac1 (in synaptic structural plasticity), and DUOX2-dependent ROS production, while its subcellular membrane recruitment is controlled by scaffolds RACK1, AnxA6, and keratin isotypes; gain-of-function kinase-domain mutation D463H (found in all chordoid gliomas) constitutively activates MAPK/ERK and displaces PKCα from the membrane, and calpain-generated catalytic fragments constitutively drive nuclear HDAC5 export and pathological gene expression in the heart.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PKC\\u03b1 (PRKCA) is a Ca2+- and lipid-responsive serine/threonine kinase that functions as a membrane-recruited signaling integrator, converting Ca2+ and diacylglycerol cues into phosphorylation of structural, transcriptional, and channel substrates across many tissues [#0, #12]. Its activity is gated by membrane recruitment, which is directed by dedicated scaffolds and cytoskeletal partners: AnxA6 brings PKC\\u03b1 to the plasma membrane to phosphorylate EGFR-T654 and dampen EGFR signaling [#6], RACK1 couples \\u03b21-integrin mechanotransduction to PKC\\u03b1 translocation [#10], and keratin isotypes either sequester PKC\\u03b1 (K5/K14) or license its translocation to drive desmosome disassembly (K6/K17) [#11]. Once active, PKC\\u03b1 phosphorylates a broad substrate set with tissue-specific consequences: inhibitor-1 to control PP-1/phospholamban and cardiac contractility [#0], the Golgi stacking protein GRASP55 to fragment the Golgi upon Ca2+ rise [#12], filamin C hinge-2 serines to block calpain cleavage at Z-discs [#18], CK1\\u03b4 C-terminal residues to tune its kinase activity [#16], TRPC1 to promote insulin secretion [#28], and the transcription factor ZFP64-S226 to activate CSF1 and macrophage-driven immune evasion [#15]. PKC\\u03b1 also operates as an upstream pathway activator\\u2014initiating an early Ca2+-dependent phase of IKK/NF-\\u03baB activation in T cells [#2], driving ERK1/2-dependent keratinocyte differentiation and NFAT5 activation [#13, #29], and promoting Rac1 activation in dendritic-spine structural plasticity [#19]. A recurrent gain-of-function kinase-domain mutation, D463H, found in chordoid gliomas, constitutively activates MAPK/ERK signaling while displacing the mutant protein from the membrane [#21, #22]. In ischemic myocardium, calpain-generated catalytic fragments of PKC\\u03b1 act constitutively in the nucleus to drive HDAC5 export and pathological gene expression [#4], and pharmacological PKC\\u03b1/\\u03b2 inhibition improves contractility in a large-animal heart-failure model [#20].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that PKC\\u03b1 acts as the Ca2+-dependent initiator of NF-\\u03baB signaling upstream of PKC\\u03b8, resolving how early TCR/CD28 signals reach IKK.\",\n      \"evidence\": \"Constitutively active/dominant-negative constructs, RNAi, pharmacology, and Ca2+-binding-residue mutagenesis in T lymphocytes with kinetic IKK assays\",\n      \"pmids\": [\"12972622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct IKK substrate of PKC\\u03b1 not defined\", \"Physical PKC\\u03b1\\u2013PKC\\u03b8 ordering inferred from kinetics, not co-complex\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined PKC\\u03b1 as a direct regulator of cardiac contractility via I-1/PP-1/phospholamban, establishing a substrate-level mechanism with whole-organ consequences.\",\n      \"evidence\": \"Prkca KO and cardiac transgenic mice, adenoviral gene transfer in cardiomyocytes, biochemical phosphorylation assays\",\n      \"pmids\": [\"14966518\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream activator of cardiac PKC\\u03b1 in vivo not isolated\", \"Relative contribution of other PKC\\u03b1 cardiac substrates unaddressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed PKC\\u03b1 in a posttranslational photic input pathway by linking it to PER2 stability and circadian resetting.\",\n      \"evidence\": \"Prkca KO mice, behavioral circadian assays, PRKCA\\u2013PER2 Co-IP and PER2 fractionation in SCN\",\n      \"pmids\": [\"17553429\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PER2 is a direct PKC\\u03b1 phospho-substrate not shown\", \"Phospho-site on PER2 unmapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed PKC\\u03b1 is required for platelet dense-granule secretion and thrombus formation, with ADP rescue ordering it upstream of granule release.\",\n      \"evidence\": \"Prkca KO mice, in vivo thrombosis and in vitro aggregation/secretion assays with ADP rescue\",\n      \"pmids\": [\"19147982\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Granule-secretion substrate of PKC\\u03b1 not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified scaffold-directed membrane recruitment as the control point for PKC\\u03b1 substrate selection, exemplified by AnxA6-mediated EGFR-T654 phosphorylation and EGFR inactivation.\",\n      \"evidence\": \"AnxA6 gain/loss constructs, cytosolic and membrane-anchored AnxA6 mutants, T654A EGFR mutant, PKC\\u03b1 siRNA, ternary Co-IP\",\n      \"pmids\": [\"22797061\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of AnxA6 scaffolding to other PKC\\u03b1 substrates untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Expanded the PKC\\u03b1 substrate map to structural and regulatory targets\\u2014filamin C, CK1\\u03b4\\u2014demonstrating direct phosphorylation events with defined functional consequences.\",\n      \"evidence\": \"In vitro kinase assays, phosphoproteomics, site-directed mutagenesis, FRAP, kinetic analysis, cellular PKC\\u03b1 inhibition\",\n      \"pmids\": [\"28028127\", \"26803658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of CK1\\u03b4 phosphorylation by PKC\\u03b1 not established\", \"Trigger for PKC\\u03b1 activation at the Z-disc not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified the recurrent D463H kinase-domain mutation as a gain-of-function oncogenic driver acting through MAPK/ERK in chordoid glioma.\",\n      \"evidence\": \"Genomic sequencing of chordoid gliomas, expression of D463H in astrocytes, phospho-ERK and soft-agar assays with MEK inhibition, replicated in two studies\",\n      \"pmids\": [\"29476136\", \"29915258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a membrane-depleted mutant achieves MAPK activation mechanistically unclear\", \"Direct ERK-activating substrate of mutant PKC\\u03b1 not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected PKC\\u03b1 to tumor immune evasion by direct phosphorylation of ZFP64-S226, driving CSF1 transcription and M2 macrophage polarization.\",\n      \"evidence\": \"MS phospho-site mapping, phospho-mutagenesis, nuclear translocation, ChIP, co-culture, orthotopic HCC xenograft\",\n      \"pmids\": [\"35219791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal activating PKC\\u03b1 in HCC not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Open question: how the diverse PKC\\u03b1 substrate repertoire and scaffold-directed localizations are selected and integrated within a single cell, and whether a unifying logic governs which substrate is engaged under a given Ca2+/DAG stimulus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated model of substrate-selection logic across tissues\", \"Most substrate phosphorylations validated in single labs/contexts\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 6, 12, 15, 16, 18, 28]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 16, 18]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 10, 11, 14]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11, 14]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 13, 19, 29]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 7, 15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"AnxA6\", \"RACK1\", \"EGFR\", \"ZFP64\", \"GRASP55\", \"CK1\\u03b4\", \"TRPC1\", \"G3BP2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}